Literature DB >> 14614853

WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production.

Shinjiro Hamano1, Kunisuke Himeno, Yoshiyuki Miyazaki, Kazunari Ishii, Atsushi Yamanaka, Atsunobu Takeda, Manxin Zhang, Hajime Hisaeda, Tak W Mak, Akihiko Yoshimura, Hiroki Yoshida.   

Abstract

WSX-1 is a class I cytokine receptor with homology to the IL-12 receptors and is essential for resistance to Leishmania major infection. In the present study, we demonstrated that WSX-1 was also required for resistance to Trypanosoma cruzi. WSX-1-/- mice exhibited prolonged parasitemia, severe liver injury, and increased mortality over wild-type mice. WSX-1-/- splenocytes produced enhanced levels of Th2 cytokines, which were responsible for the prolonged parasitemia. Massive necroinflammatory lesions were observed in the liver of infected WSX-1-/- mice, and IFN-gamma that was overproduced in WSX-1-/- mice compared with wild-type mice was responsible for the lesions. In addition, vast amounts of various proinflammatory cytokines, including IL-6 and TNF-alpha, were produced by liver mononuclear cells in WSX-1-/- mice. Thus, during T. cruzi infection, WSX-1 suppresses liver injury by regulating production of proinflammatory cytokines, while controlling parasitemia by suppression of Th2 responses, demonstrating its novel role as an inhibitory regulator of cytokine production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614853     DOI: 10.1016/s1074-7613(03)00298-x

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  98 in total

1.  Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1.

Authors:  Kiyoshi Hirahara; Kamran Ghoreschi; Xiang-Ping Yang; Hayato Takahashi; Arian Laurence; Golnaz Vahedi; Giuseppe Sciumè; Aisling O'Hara Hall; Christopher D Dupont; Loise M Francisco; Qian Chen; Masao Tanaka; Yuka Kanno; Hong-Wei Sun; Arlene H Sharpe; Christopher A Hunter; John J O'Shea
Journal:  Immunity       Date:  2012-06-21       Impact factor: 31.745

Review 2.  Dendritic cell-mediated T cell polarization.

Authors:  Esther C de Jong; Hermelijn H Smits; Martien L Kapsenberg
Journal:  Springer Semin Immunopathol       Date:  2004-10-14

3.  The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses.

Authors:  Shaun A Summers; Richard K S Phoon; Joshua D Ooi; Stephen R Holdsworth; A Richard Kitching
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants.

Authors:  Francois Rousseau; Laetitia Basset; Josy Froger; Nathalie Dinguirard; Sylvie Chevalier; Hugues Gascan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 5.  Negative regulation of Th17 responses.

Authors:  J S Stumhofer; J Silver; C A Hunter
Journal:  Semin Immunol       Date:  2008-01-24       Impact factor: 11.130

6.  Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.

Authors:  Teresa M Wozniak; Anthony A Ryan; James A Triccas; Warwick J Britton
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.

Authors:  Mariana Tomazini Pinto; Tathiane Maistro Malta; Evandra Strazza Rodrigues; Daniel Guariz Pinheiro; Rodrigo Alexandre Panepucci; Kelen Cristina Ribeiro Malmegrim de Farias; Alessandra De Paula Sousa; Osvaldo Massaiti Takayanagui; Yuetsu Tanaka; Dimas Tadeu Covas; Simone Kashima
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-16       Impact factor: 2.205

8.  Impact of Interleukin-27p28 on T and B Cell Responses during Toxoplasmosis.

Authors:  Jeongho Park; Jonathan H DeLong; James J Knox; Christoph Konradt; Elia D Tait Wojno; Christopher A Hunter
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

Review 9.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

Review 10.  A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes.

Authors:  Noriko Morishima; Izuru Mizoguchi; Masae Okumura; Yukino Chiba; Mingli Xu; Motomu Shimizu; Masanori Matsui; Junichiro Mizuguchi; Takayuki Yoshimoto
Journal:  J Biomed Biotechnol       Date:  2010-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.